Department of Bioengineering and Therapeutic Sciences

School of Pharmacy tops pharmacy schools in NIH funding for 39th straight year

Wed Feb 27, 2019
Kroetz and colleague review the results of an experiment
Elisabeth Fall

Deanna Kroetz, PhD (right) was among dozens of faculty members who contributed to the School of Pharmacy becoming the top recipient of NIH funding among all pharmacy schools in 2018.

Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.

USP/UCSF fellowship to support research in the quality and safety of medical products

Wed Feb 27, 2019
Pharmaceutical drugs
© majedphoto.com

The UCSF Fellowship in Quality of Medical Products will support research into excipients, or inactive ingredients found in pharmaceutical drugs.

A new fellowship, funded jointly by UCSF-Stanford CERSI and the U.S. Pharmacopeial Convention (USP), will support research into the inactive components of medications, which are known as excipients.

CP159: Certificate in Resiliency Medicine Training: Immunizing for Stress

Wed Feb 13, 2019
About the course

We will explore the current research and demonstrate and practice resiliency building tools including a cross-section of mind-body interactions and internal narratives (story telling). Course completion requires teaching and modeling resiliency skills. Those who successfully...

Gift of $500,000 honors Jere E. Goyan, late UCSF School of Pharmacy dean

Tue Feb 12, 2019
Goyan
UC Regents

Jere E. Goyan, PhD, was the longest-serving dean of the School of Pharmacy and commissioner of the FDA.

The endowment will provide funds for a recipient to focus on delivering breakthroughs in therapeutics-related research, education, and patient care.

CRISPR-based obesity treatment shows promise for other diseases

Thu Jan 17, 2019
Ahituv, right, works in his lab with postdoc Fumitaka Inoue
Susan Merrell

Nadav Ahituv, PhD, right, was able to curb obesity in mice by tweaking two genes involved in controlling appetite.

A recent study by Nadav Ahituv, PhD, showed that obesity caused by a gene mutation could be treated in animal models.

COSA Winter Auction

Fri Jan 11, 2019

Fraser appointed to Bowes Biomedical Investigator Program

Wed Jan 9, 2019
Fraser stands in front of a whiteboard
Elisabeth Fall

James Fraser, PhD, developed new ways of doing crystallography over a wide range of temperatures.

Fraser developed several new tools for creating maps of macromolecules, a critical first step for finding new drugs.

Seth Shipman, PhD

Fri Dec 21, 2018
Shipman
Associate Professor

My lab develops molecular biotechnology to overcome technical hurdles that prevent us from effectively understanding and treating disease. We're particularly interested in neurodevelopmental and neurodegenerative disease.

Combination drug therapy overcomes drug-resistant lung cancer in the lab

Wed Dec 19, 2018
Chest x-ray, showing a possible lung cancer tumor.
National Cancer Institute

A chest x-ray showing a possible lung cancer tumor (National Cancer Institute)

Many types of lung cancer thwart even the most targeted of therapies due to drug resistance, but a group of UCSF scientists led by Sourav Bandyopadhyay, PhD, have now shown that adding a second drug into treatment regimens can overcome this resistance in lab-grown, lung cancer cell lines.

Research points to individualized treatments for curing TB

Tue Nov 20, 2018
Savic speaking at podium

Rada Savic, PhD, senior author on the study, presented her team's work on tuberculosis treatments at the 49th Union World Conference on Lung Health in The Hague, The Netherlands, in late October 2018.

Tuberculosis is usually treated with a six month regimen of daily antibiotics, but millions of patients do not recover from the disease during treatment. Rada Savic’s team showed that adjusting the duration of this regimen based on disease severity could lead to better outcomes.

Pages